YONGHE MED.GR.DL-0000025 (L97) — Working Capital to Net Assets Ratio
YONGHE MED.GR.DL-0000025 (L97) has a Working Capital to Net Assets ratio of 38.6% as of December 2025. Working capital of €304.20 Million (current assets of €853.50 Million minus current liabilities of €549.30 Million) is measured against net assets of €787.37 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See L97 equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
YONGHE MED.GR.DL-0000025 Working Capital to Net Assets (2021–2025)
This chart shows how YONGHE MED.GR.DL-0000025's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 38.6%, reflecting working capital of €304.20 Million against net assets of €787.37 Million EUR. Check YONGHE MED.GR.DL-0000025 (L97) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for YONGHE MED.GR.DL-0000025 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for YONGHE MED.GR.DL-0000025 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see YONGHE MED.GR.DL-0000025 stock valuation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 38.6% | €304.20 Million | €787.37 Million | €853.50 Million | €549.30 Million | ▲ +26.9 pp |
| 2024 | 11.8% | €84.10 Million | €713.80 Million | €629.82 Million | €545.71 Million | ▲ +2.6 pp |
| 2023 | 9.2% | €86.42 Million | €942.25 Million | €809.33 Million | €722.90 Million | ▼ -34.4 pp |
| 2022 | 43.6% | €690.97 Million | €1.59 Billion | €1.19 Billion | €498.51 Million | ▼ -15.9 pp |
| 2021 | 59.5% | €1.01 Billion | €1.70 Billion | €1.75 Billion | €737.68 Million | — |